Allogene Therapeutics raises $110M in registered equity offering at $2.90 per share with insider participation

Allogene Therapeutics, Inc.

Offering of 37,931,035 shares at $2.90 per share for gross proceeds of ~$110M; expected to close May 16, 2024.
Insiders Arie Belldegrun, David Chang, and Geoffrey Parker each purchasing 344,828 shares in the offering.
Goldman Sachs & Co. LLC acted as sole underwriter; offering made under effective shelf registration statement.
Net proceeds after underwriting discounts and expenses will be used for general corporate purposes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.